| Literature DB >> 24411212 |
Samuel Christen1, Mario Mendoza2, Rita Gobet3, Peter Bode4, Daniel Weber3.
Abstract
Various biological and artificial materials have been introduced for endoscopic treatment of vesicoureteral reflux. Over the past years, dextranomer combined with hyaluronic acid (Dx/Ha) has been established as the most commonly used tissue-augmenting substance for subureteral injection because of its biocompatibility. Nevertheless, the histopathologic analysis of failed Dx/Ha injections showed changes in consistency and volume of the deposit and granulomatous reactions of the adjacent tissue. We report a case of late-onset obstruction 2 years after the injection of Dx/Ha. In the current literature, this potential long-term complication is hardly mentioned.Entities:
Mesh:
Substances:
Year: 2014 PMID: 24411212 DOI: 10.1016/j.urology.2013.10.053
Source DB: PubMed Journal: Urology ISSN: 0090-4295 Impact factor: 2.649